Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. PIMA1024HRP

TRA-1-81 Monoclonal Antibody (TRA-1-81), HRP, Invitrogen™

Catalog No. PIMA1024HRP
Change view
Click to view available options
Quantity:
100 μL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
PIMA1024HRP 100 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. PIMA1024HRP Supplier Thermo Scientific Supplier No. MA1024HRP

Description

Mouse Monoclonal Antibody

MA1-024-HRP has been successfully used in Western blot applications on human samples.

TRA-1-81 Monoclonal antibody specifically detects TRA-1-81 in Human samples. It is validated for Western Blot.
TRUSTED_SUSTAINABILITY

Specifications

Antigen TRA-1-81
Applications Western Blot
Classification Monoclonal
Clone TRA-1-81
Concentration 1 mg/mL
Conjugate HRP
Formulation proprietary buffer with proprietary stabilizer and 0.07% Kathon
Gene Alias GCTM-2 antigen; Gp200; PC; PCLP; PCLP1; PCLP-1; Podocalyxin; podocalyxin like; podocalyxin-like; podocalyxin-like protein 1; PODXL; TRA180; tra1-81
Host Species Mouse
Immunogen human embryonal carcinoma cell line 2102Ep
Purification Method Affinity chromatography - MBP
Quantity 100 μL
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage 4° C, do not freeze
Product Type Antibody
Form Liquid
Isotype IgM
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.